DPS Group and Aizon discuss how artificial intelligence is enabling adaptive modeling in process development and integrating activities in biomanufacturing.
URGENT APPEAL - THE OBSERVATORY New information TUR 002 / 0321 / OBS 039.1 Judicial harassment Turkey January 31, 2022 The Observatory for the Protection…
Besides Omicron, the industry will focus on RNA-based drugs, AI programs, gene therapy trials, financing deals, regulatory issues, and synthetic biology challenges.